InvestorsHub Logo
Followers 63
Posts 8097
Boards Moderated 1
Alias Born 10/30/2015

Re: Poor Man - post# 17024

Sunday, 05/08/2016 10:00:23 PM

Sunday, May 08, 2016 10:00:23 PM

Post# of 106824
Correction:

Got the timing wrong. The number of common shares outstanding at year end was approximately 1.8 million.

The number of shares outstanding of the registrant’s Common Stock, $0.001 par value, as of March 8th, 2016 was 2,470,400.

That means U.S. Stem Cell doubled the number of shares outstanding to over 5 million, not in four months as I previously wrote, but (amazingly) doubled the number of outstanding shares in less than two months!!! Strictly my opinion, but this pace of dilution is unsustainable.